{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:13:08Z","timestamp":1793643188569,"version":"4.5.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-C"],"award-info":[{"award-number":["2021-I2M-C"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["T-A-010"],"award-info":[{"award-number":["T-A-010"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201806210439"],"award-info":[{"award-number":["201806210439"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ebiom.2023.104543","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T07:33:45Z","timestamp":1680161625000},"page":"104543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"special_numbering":"C","title":["Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Ziang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-3315","authenticated-orcid":false,"given":"Shuai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5434-5798","authenticated-orcid":false,"given":"Yongjian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"10290","key":"10.1016\/j.ebiom.2023.104543_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104543_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14309\/ajg.0000000000000845","article-title":"Effects of statin use on the development and progression of nonalcoholic fatty liver disease: a nationwide nested case-control study","volume":"116","author":"Lee","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104543_bib6","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.31599","article-title":"NAFLD: reporting histologic findings in clinical practice","volume":"73","author":"Brunt","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104543_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2019.04.019","article-title":"Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD","volume":"71","author":"Rinella","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.gastro.2015.11.017","article-title":"End points must be clinically meaningful for drug development in nonalcoholic fatty liver disease","volume":"150","author":"Sanyal","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104543_bib9","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities","volume":"46","author":"Walker","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"42","key":"10.1016\/j.ebiom.2023.104543_bib10","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1093\/eurheartj\/ehac394","article-title":"From the garden to the clinic: how Mendelian randomization is shaping up atherosclerotic cardiovascular disease prevention strategies","volume":"43","author":"Arsenault","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib11","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104543_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.118.038814","article-title":"Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects","volume":"140","author":"Gill","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104543_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","article-title":"Advancing the use of genome-wide association studies for drug repurposing","volume":"22","author":"Reay","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104543_bib14","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ebiom.2023.104543_bib15","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ana.25642","article-title":"Lipid lowering and Alzheimer disease risk: a mendelian randomization study","volume":"87","author":"Williams","year":"2020","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104543_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.2020.0150","article-title":"Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer","volume":"323","author":"Yarmolinsky","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamacardio.2017.4293","article-title":"Genetic association of lipids and lipid drug targets with abdominal aortic aneurysm: a meta-analysis","volume":"3","author":"Harrison","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"16","key":"10.1016\/j.ebiom.2023.104543_bib19","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104543_bib20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.ebiom.2023.104543_bib22","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104543_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Bor\u00e9n","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"9943","key":"10.1016\/j.ebiom.2023.104543_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(14)61009-6","article-title":"LDL cholesterol: controversies and future therapeutic directions","volume":"384","author":"Ridker","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104543_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/CIRCGENETICS.114.000952","article-title":"Effect of bile acid sequestrants on the risk of cardiovascular events: a mendelian randomization analysis","volume":"8","author":"Ross","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104543_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2022.05.041","article-title":"Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function","volume":"80","author":"Rosoff","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6509","key":"10.1016\/j.ebiom.2023.104543_bib27","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx consortium atlas of genetic regulatory effects across human tissues","volume":"369","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104543_bib28","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104543_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort","volume":"73","author":"Anstee","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104543_bib30","article-title":"Machine learning enables new insights into genetic contributions to liver fat accumulation","volume":"1","author":"Haas","year":"2021","journal-title":"Cell Genom"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib31","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/s41467-021-22338-2","article-title":"Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes","volume":"12","author":"Pazoki","year":"2021","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.ebiom.2023.104543_bib32","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104543_bib33","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","article-title":"Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes","volume":"9","author":"Xue","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104543_bib34","first-page":"1121","article-title":"A\u00a0comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104543_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104543_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104543_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/genes13091541","article-title":"TwoStepCisMR: a novel method and R package for attenuating bias in cis-mendelian randomization analyses","volume":"13","author":"Woolf","year":"2022","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104543_bib38","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038984","article-title":"Multivariable mendelian randomization and mediation","volume":"11","author":"Sanderson","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104543_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001547","article-title":"Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation","volume":"20","author":"Richardson","year":"2022","journal-title":"PLoS Biol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104543_bib40","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/eurheartj\/ehaa972","article-title":"Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104543_bib41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104543_bib42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.32728","article-title":"The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study","volume":"77","author":"Xie","year":"2022","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104543_bib43","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","article-title":"Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease","volume":"25","author":"Mato","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"21","key":"10.1016\/j.ebiom.2023.104543_bib44","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104543_bib45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2018.2866","article-title":"Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes","volume":"3","author":"Lotta","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104543_bib46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104543_bib47","article-title":"Non-alcoholic fatty liver in patients with chylomicronemia","volume":"10","author":"Maltais","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ebiom.2023.104543_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2014.10.029","article-title":"The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome","volume":"440","author":"Shirakawa","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104543_bib49","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.metabol.2005.06.005","article-title":"NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats","volume":"54","author":"Kusunoki","year":"2005","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104543_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bmcl.2016.11.053","article-title":"Structure-activity and in\u00a0vivo evaluation of a novel lipoprotein lipase (LPL) activator","volume":"27","author":"Geldenhuys","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104543_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drudis.2016.10.007","article-title":"Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases","volume":"22","author":"Geldenhuys","year":"2017","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104543_bib52","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.27678","article-title":"Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop","volume":"61","author":"Sanyal","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104543_bib53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104543_bib54","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40265-019-01114-z","article-title":"Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials","volume":"79","author":"Fogacci","year":"2019","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104543_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-020-00493-1","article-title":"Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development","volume":"18","author":"Holmes","year":"2021","journal-title":"Nat Rev Cardiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:24:46Z","timestamp":1762457086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":55,"alternative-id":["S2352396423001081"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104543","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104543"}}